The cardiovascular risk of febuxostat among patients with hyperuricemia or gout compared with allopurinol: A population-based study in Taiwan

被引：0
|
作者：
Huang, Chien-Huei [1 ]
Su, Chien-Chou [2 ,3 ]
Liu, Pheng-Ying Yeh [1 ]
Yang, Yea-Huei Kao [2 ,3 ]
Cheng, Ching-Lan [2 ,3 ]
机构：
[1] Natl Cheng Kung Univ Hosp, Dept Pharm, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
85
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [1] Febuxostat compared with allopurinol in patients with hyperuricemia and gout
    Becker, MA
    Schumacher, HR
    Wortmann, RL
    MacDonald, PA
    Eustace, D
    Palo, WA
    Streit, J
    Joseph-Ridge, N
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23): : 2450 - 2461
  • [2] Febuxostat compared with allopurinol in patients with hyperuricemia and gout. Results of the FACT study
    不详
    KARDIOLOGIYA, 2006, 46 (07) : 79 - 79
  • [3] Risk of Cardiovascular Events in Older Patients with Gout Initiating Febuxostat Versus Allopurinol: A Population-Based Cohort Study
    Zhang, MaryAnn
    Liu, Jun
    Kang, Eun Ha
    Desai, Rishi J.
    Neogi, Tuhina
    Solomon, Daniel H.
    Kim, Seoyoung C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study
    Zhang, MaryAnn
    Solomon, Daniel H.
    Desai, Rishi J.
    Kang, Eun Ha
    Liu, Jun
    Neogi, Tuhina
    Kim, Seoyoung C.
    CIRCULATION, 2018, 138 (11) : 1116 - 1126
  • [5] Febuxostat or Allopurinol in Patients with Gout Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES)
    Alten, R.
    Mischkewitz, M.
    Nitschmann, S.
    INTERNIST, 2020, 61 (05): : 530 - 532
  • [6] Letter by Kuwabara Regarding Article, "Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study"
    Kuwabara, Masanari
    CIRCULATION, 2019, 139 (10) : 1348 - 1349
  • [7] Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    White, William B.
    Saag, Kenneth G.
    Becker, Michael A.
    Borer, Jeffrey S.
    Gorelick, Philip B.
    Whelton, Andrew
    Hunt, Barbara
    Castillo, Majin
    Gunawardhana, Lhanoo
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1200 - 1210
  • [8] Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia
    Ghossan, Roba
    Tabesh, Ouidade Aitisha
    Fayad, Fouad
    Richette, Pascal
    Bardin, Thomas
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2024, 30 (02) : e46 - e53
  • [9] COMPARATIVE RISK OF RETINAL VASCULAR COMPLICATIONS IN PATIENTS WITH GOUT INITIATING FEBUXOSTAT VERSUS ALLOPURINOL: A POPULATION-BASED COHORT STUDY
    Kim, M. J.
    Shin, A.
    Choi, S. R.
    Ha, Y. J.
    Lee, Y. J.
    Lee, E. B.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 320 - 320
  • [10] Is febuxostat associated with higher risk of cardiovascular death than allopurinol in treating gout or asymptomatic hyperuricemia?
    Deng, Jian-Hao
    Zhong, Guo-Wei
    Zhang, Jia-Xing
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (08) : 2789 - 2791
12345